Inventor · disambiguated record
David A. Ostrov
Also filed as: OSTROV DAVID · OSTROV DAVID A · OSTROV DAVID ABEL
20 granted patents·19 pending applications·32 citations·filing 2006–2022
91Inventor score
Top patents by PatentIndex Score
39 records- 0190US8436013B2Compounds and methods for treatment of alpha-1 antitrypsin deficiencyLIU CHEN·Filed 2009·Granted May 7, 2013·14 cites·8 claims
- 0279US8492344B2PDK inhibitor compounds and methods of use thereofOSTROV DAVID A·Filed 2009·Granted Jul 23, 2013·2 cites·11 claims
- 0378US9301965B2Method of treating ovarian cancer using a PKC inhibitorACEVEDO-DUNCAN MILDRED ENID·Filed 2015·Granted Apr 5, 2016·4 cites·12 claims
- 0476US9629848B2Compounds that modulate autoimmunity and methods of using the sameMICHELS AARON·Filed 2012·Granted Apr 25, 2017·5 cites·3 claims
- 0575US10918650B2Method of treating melanoma using an inhibitor of an atypical protein kinase CUNIV SOUTH FLORIDA·Filed 2017·Granted Feb 16, 2021·1 cites·3 claims
- 0672US8545841B2Methods and compositions for the treatment of cancers and pathogenic infectionsDUNN WILLIAM A·Filed 2009·Granted Oct 1, 2013·2 cites·16 claims
- 0769US8623854B2Nuclear export inhibitors of topoisomerase II alphaSULLIVAN DANIEL M·Filed 2011·Granted Jan 7, 2014·1 cites·8 claims
- 0868US9351981B2Use of PKC-iota inhibitors for the treatment of breast cancerACEVEDO-DUNCAN MILDRED ENID·Filed 2011·Granted May 31, 2016·2 cites·8 claims
- 0967US11065266B2Method of treating melanoma using an inhibitor of an atypical protein kinase CUNIV SOUTH FLORIDA·Filed 2019·Granted Jul 20, 2021·0 cites·9 claims
- 1067US8314150B2Kinase protein binding inhibitorsCANCE WILLIAM G·Filed 2009·Granted Nov 20, 2012·0 cites·14 claims
- 1166US2022241226A1Method of Treating Colorectal Cancers Using a PKC InhibitorUNIV SOUTH FLORIDA·Filed 2022·Application pending·0 cites
- 1262US8815828B2Therapeutic combinations for use in neoplasiaNARAYAN SATYA·Filed 2009·Granted Aug 26, 2014·0 cites·2 claims
- 1361US8404669B2Kinase modulating compounds and uses thereof for treatment of cancerCANCE WILLIAM G·Filed 2008·Granted Mar 26, 2013·0 cites·11 claims
- 1460US9616051B2Drug targets to overcome de novo drug-resistance in multiple myelomaH LEE MOFFITT CANCER CT & RES·Filed 2013·Granted Apr 11, 2017·0 cites·16 claims
- 1558US9144596B2Compositions and methods of treating neoplasiaNARAYAN SATYA·Filed 2008·Granted Sep 29, 2015·0 cites·8 claims
- 1658US2024115667A1Diphenhydramine and lactoferrin for prevention and treatment of covid-19UNIV FLORIDA·Filed 2021·Application pending·0 cites
- 1757US11337944B2Method of treating colorectal cancers using a PKC inhibitorUNIV SOUTH FLORIDA·Filed 2017·Granted May 24, 2022·0 cites·11 claims
- 1857US2009286808A1Opsin Stabilizing Compounds and Methods of UseUNIV FLORIDA·Filed 2009·Application pending·0 cites
- 1956US2023272024A1Fibroblast growth factor 7 peptideUNIV FLORIDA·Filed 2021·Application pending·0 cites
- 2055US2024307370A1Sigma receptor ligands for treating sars-cov-2 infectionUNIV FLORIDA·Filed 2022·Application pending·0 cites
- 2155US2023129326A1Methods to prevent sars-cov-2 infection and treat covid-19UNIV FLORIDA·Filed 2021·Application pending·0 cites
- 2253US8461192B2Method of selectively inhibiting PKCiotaACEVEDO-DUNCAN MILDRED·Filed 2008·Granted Jun 11, 2013·1 cites·6 claims
- 2353US2013079297A1Kinase protein binding inhibitorsUNIV FLORIDA RES FOUNDA·Filed 2012·Application pending·0 cites
- 2452US2012046246A1Methods for treating osteoclast-related disease, compounds and compositions thereofHOLLIDAY LEXIE SHANNON·Filed 2009·Application pending·0 cites
- 2552US2011230564A1Ant4 inhibitor compounds and methods of use thereofUNIV FLORIDA·Filed 2009·Application pending·0 cites
- 2652US2008021354A1Device for increasing focus through alternating stimulationsOSTROV DAVID ABEL·Filed 2006·Application pending·0 cites
- 2750US8569356B2Cyclin dependent kinase inhibitorsOSTROV DAVID A·Filed 2006·Granted Oct 29, 2013·0 cites·8 claims
- 2850US2023092232A1Compounds that modulate anti-tumor immunity and methods of doing the sameUNIV FLORIDA·Filed 2021·Application pending·0 cites
- 2947US12331333B2Enhancers of neurolysin activityUNIV TEXAS TECH SYSTEM·Filed 2021·Granted Jun 17, 2025·0 cites·5 claims
- 3045US2011110958A1Compositions and methods for the treatment of neoplasiaUNIV FLORIDA·Filed 2008·Application pending·0 cites
- 3143US9517244B2Therapeutic combinations for use in neoplasiaNARAYAN SATYA·Filed 2012·Granted Dec 13, 2016·0 cites·6 claims
- 3242US2012142723A1Ace2 activator compounds and methods of use thereofOSTROV DAVID A·Filed 2007·Application pending·0 cites
- 3341US2012100227A1Kinase protein binding inhibitorsGOLUBOVSKAYA VITA·Filed 2010·Application pending·0 cites
- 3440US2018116988A1Methods of preventing and treating autoimmunityUNIV COLORADO REGENTS·Filed 2016·Application pending·0 cites
- 3537US2012107323A1Kinase protein binding inhibitorsHOCHWALD STEVEN N·Filed 2010·Application pending·0 cites
- 3635US2018297966A1Compounds, compositions, and methods of making and using the sameINNOVATIVE ANESTHETICS LLC·Filed 2016·Application pending·0 cites
- 3734US2013165417A1Methods and compositions for treating ace2-related disordersRAIZADA MOHAN K·Filed 2011·Application pending·0 cites
- 3833US8501242B2Methods and compositions for treating neoplasiaOSTROV DAVID A·Filed 2010·Granted Aug 6, 2013·0 cites·10 claims
- 3924US2012195929A1Compounds that modulate autoimmunity and methods of using the sameEISENBARTH GEORGE·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David A. Ostrov files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →